과학
중도 성향
STAT+: A year after distressed buyout, what’s become of Bluebird Bio?
STAT News
조회 0
이 뉴스, 어떠셨어요?
한 번의 탭으로 반응을 남겨요 · 로그인 불필요
Bluebird Bio was a dark biotech morality tale when David Meek bought it.
He says the new company, Genetix, is already making money. ...
관련 뉴스
관련 뉴스 제보는 로그인 후 가능합니다.
'science' 카테고리 뉴스
STAT의 다른 기사
STAT+: A ‘historic’ FDA clearance raises the question: Is LLM the interface? Or the decision-maker?
STAT News
The new presidential fitness test is a positive step, not the solution, experts say
STAT News
STAT+: A former AI regulator, now in industry, says biopharma is reading FDA’s guidance wrong
STAT News